Moleculin Announces the FDA has Granted Orphan Drug Designation for its Brain Tumor Drug
HOUSTON, Feb. 05, 2019 (GLOBE NEWSWIRE) — Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a clinical stage pharmaceutical […]
CDK Global Reports Second Quarter Fiscal 2019 Results
ASC 606 Second Quarter Results Revenues of $590.4 million GAAP net earnings attributable to CDK of $89.0 million and adjusted […]
OpGen Completes Clinical Trials for its Initial FDA 510(k) Submission
GAITHERSBURG, Md., Feb. 05, 2019 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN) announced today that it has completed the clinical […]
VR Samples 58.3 g/t Gold and 809 g/t Silver and Stakes New Property to Expand Its Danbo Property Epithermal Gold Trend in Nevada
VANCOUVER, British Columbia, Feb. 05, 2019 (GLOBE NEWSWIRE) — VR Resources Ltd. (TSX.V: VRR, FSE: 5VR; OTCBB: VRRCF), the “Company”, […]
Datametrex Announces Cannabis AI Pilot Program With Empower
TORONTO, Feb. 05, 2019 (GLOBE NEWSWIRE) — Datametrex AI Limited (TSXV:DM) (the “Company” or “Datametrex”) is pleased to announce its […]
Former Congresswoman Lynn Jenkins Joins MGP Ingredients Board of Directors
ATCHISON, Kan., Feb. 05, 2019 (GLOBE NEWSWIRE) — MGP Ingredients, Inc. (Nasdaq:MGPI), a leading supplier of premium distilled spirits and […]
Protalix BioTherapeutics Presents Preliminary Data from the BRIGHT Study of pegunigalsidase alfa for the Treatment of Fabry Disease at the 15th Annual WORLDSymposium™ 2019
~Pharmacokinetic data from patients treated in the study show that infusion of pegunigalsidase alfa every 4 weeks results in the presence […]
Kamada to Announce Fourth Quarter and Fiscal Year Ended December 31, 2018 Financial Results and Host Conference Call on February 12
REHOVOT, Israel, Feb. 05, 2019 (GLOBE NEWSWIRE) — Kamada Ltd. (NASDAQ & TASE: KMDA), a plasma-derived protein therapeutics company, today […]
Cyclacel Pharmaceuticals to Present at the 2019 BIO CEO & Investor Conference
BERKELEY HEIGHTS, N.J., Feb. 05, 2019 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), […]
Hamilton Lane Incorporated Reports Third Quarter Fiscal 2019 Results
BALA CYNWYD, Pa., Feb. 05, 2019 (GLOBE NEWSWIRE) — Leading private markets asset management firm Hamilton Lane Incorporated (NASDAQ: HLNE) […]
